Guggenheim Capital’s Collegium Pharmaceutical COLL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$202K	Sell	6,096 -25,566	-81%	-$1.08M	﹤0.01%	1523
2025 Q4	$1.47M	Buy	+31,662	New	+$1.32M	0.01%	772
2024 Q3	–	Sell	-32,038	Closed	-$1.03M	–	1879
2024 Q2	$1.03M	Buy	32,038 +17,525	+121%	+$608K	0.01%	1101
2024 Q1	$563K	Buy	+14,513	New	+$508K	﹤0.01%	1429
2022 Q3	–	Sell	-39,309	Closed	-$697K	–	1934
2022 Q2	$697K	Buy	39,309 +2,116	+6%	+$35.6K	0.01%	1407
2022 Q1	$757K	Sell	37,193 -465	-1%	-$8.79K	﹤0.01%	1498
2021 Q4	$703K	Sell	37,658 -4,068	-10%	-$79.3K	﹤0.01%	1518
2021 Q3	$823K	Sell	41,726 -7,797	-16%	-$169K	0.01%	1520
2021 Q2	$1.17M	Sell	49,523 -1,926	-4%	-$44.5K	0.01%	1402
2021 Q1	$1.22M	Buy	51,449 +19,879	+63%	+$472K	0.01%	1295
2020 Q4	$632K	Buy	31,570 +11,392	+56%	+$222K	﹤0.01%	1538
2020 Q3	$420K	Buy	+20,178	New	+$364K	﹤0.01%	1505